StanfordHealthPolicy
@StanfordHP
The official account of Stanford Health Policy: Innovative, cross-discipline research on health policy and primary care outcomes. RTs are not endorsements.
ID:24029533
http://healthpolicy.fsi.stanford.edu 12-03-2009 20:31:30
26,9K Tweets
7,7K Followers
5,2K Following
Last day to register for Tuesday's #RosenkranzGlobal Health Policy Research Symposium! A dozen academics from around the world present innovative research; keynote by Mark Dybul, former director of PEPFAR and the Global Fund to Fight AIDS, TB and Malaria.
bit.ly/3WEnPBB
What Happens When Patients Lose Their Long-Term Opioid Treatment? A study by SHP's Adrienne Sabety examines the association between prescriber workforce exit, long-term opioid treatment discontinuation, and clinical outcomes.
healthpolicy.fsi.stanford.edu/news/what-happ…
Could avian flu be our next pandemic threat?⬇️
'This virus has the potential to seriously disrupt our agricultural supplies & also jump from other mammals to humans,' says Stanford Center for Innovation in Global Health's Michele Barry, noting it's time to take critical preventive action.
scopeblog.stanford.edu/2024/05/14/bir…
Join us next Tuesday for #RosenkranzGlobal keynote by ambassador Mark Dybul, former director of PEPFAR & Global Fund to Fight AIDS, TB and Malaria. Come hear his unique perspective on the evolution and future of health in the current global context.
bit.ly/3WEnPBB
This Is a Very Weird Moment in the History of Drug Laws.
SHP's Keith Humphreys joins Ezra Klein to talk about how US drug policy feels very unsettled right now.
nytimes.com/2024/05/10/opi…
🗓️ SAVE THE DATE | May 21 is StanfordHealthPolicy's annual #RosenkranzGlobal Health Policy Research Symposium!
The Protecting Health Care for All Patients Act passed by the U.S. House of Representatives may compromise the evaluation of medical treatments and ultimately do more harm than good to patients, caution scholars at StanfordHealthPolicy. ow.ly/jrsU50Rwmtz
US House QALY Ban Could Harm, Not Help, People with Disabilities and Chronic Illness, argue SHP's Josh Salomon and colleagues in this Health Affairs commentary. ⚕️ 'We believe the bill would compromise the evaluation of medical treatments.'
healthpolicy.fsi.stanford.edu/news/qaly-ban-…
Catch up on all the latest news, research, and updates from StanfordHealthPolicy in their May Newsletter! ⤵️
Removing Race Adjustment in Chronic Kidney Disease Care. A new study led by SHP researchers finds that algorithmic changes to a #CKD care equation are likely insufficient to achieve health equity as other structural inequities remain. #KidneyDisease
healthpolicy.fsi.stanford.edu/news/removing-…
Come work with us! We are hiring a health economic modeler/software developer to join our team at StanfordHealthPolicy Stanford Medicine @Stanford The successful candidate will join my modeling team that conducts modeling analyses on... phxc1b.rfer.us/STANFORD.2rQK0
Lives on the Line: In conflict zones and borderlands, SHP's Paul Wise protects the health of vulnerable children around the world. His work is featured in Stanford Alumni magazine. 🌎⚕️ Paul H Wise
stanfordmag.org//contents/live…
Stanford team wins The Patient-Centered Outcomes Research Institute funding to build ethical assessment process for healthcare AI.
“It’s important to us to bring patients’ voices into the conversation,” says SHP's Michelle Mello, a member of the Stanford Medicine team building ethical review tool.
healthpolicy.fsi.stanford.edu/news/stanford-…
SHP's Eran Bendavid & colleagues find dust pollution from the massive desert storms in sub-Saharan Africa is as great a risk to the region’s children as major killers like malaria or the flu. #EarthDay2024
stanmed.stanford.edu/solving-enviro…
